NOCISCAN

About Aclarion

Aclarion, founded in 2014 and based in Broomfield, Colorado, is a commercial-stage diagnostics company focused on the chronic low back pain market. The company's core innovation is the NOCISCAN platform, which applies MR spectroscopy to detect specific pain-associated biomarkers (lactate and pH) within intervertebral discs, providing a NOCI+/NOCI- score for each disc. This objective data is designed to help physicians pinpoint the source of pain more accurately than structural imaging alone, potentially leading to better-targeted treatments and improved surgical outcomes. Aclarion operates on a SaaS model, commercializing its evidence-supported technology to spine specialists and surgical centers.

Therapeutic Areas